Ireland
GlaxoSmithKline review leads to 121 layoffs in Cork
October 7, 2010Manufacturing and Production GlaxoSmithKline, Ireland, job cuts
GlaxoSmithKline has completed its review of a manufacturing facility in Ireland and concluded that it will have to shed 121 …
GSK workers in Ireland await review
September 20, 2010Manufacturing and Production, Research and Development GlaxoSmithKline, Ireland, job cuts
Workers at a GlaxoSmithKline facility in Ireland are anxiously awaiting the outcome of an official review of the operation amid …
Merck plans jobs cuts in Ireland
September 10, 2010Manufacturing and Production Ireland, Merck & Co, Schering-Plough, job cuts
A manufacturing plant in Ireland is the latest to face staff cuts in the wake of Merck & Co’s merger …
Teva staff in Ireland vote for industrial action
June 3, 2010Manufacturing and Production Ireland, Teva
Workers at a plant operated by Teva in Ireland have voted to take industrial action in a dispute over redundancy …
Investments boost Irish pharma sector
March 11, 2010Research and Development, Sales and Marketing Ireland, PPD, Warner Chilcott
Contract research organisation PPD has officially opened its new research laboratory in Athlone, Ireland, and started recruiting for the first …
Pfizer to set up new lab in Ireland
July 10, 2009Manufacturing and Production Europe, Ireland, Pfizer
Pfizer has earmarked an 11 million euro investment for a new kilo-scale R&D facility at its manufacturing facility in Ringaskiddy, …
Merck hikes investment in Irish biologics plant
March 30, 2009Manufacturing and Production Europe, Ireland
Merck & Co has increased its investment in a new biologic and vaccines facility in Carlow, Ireland, to 220 million …
Daiichi Sankyo sets up Ireland operations
November 27, 2008Sales and Marketing Daiichi, Ireland
Japanese company Daiichi Sankyo is continuing its expansion in Europe with the launch of operations in Ireland.The new subsidiary's headquarters …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
